C

CAVO A.

Last name: CAVO A.

2022 (v1)

Publication

Metadata-only

IMMUNE TUMOR MICROENVIRONMENT (I-TME) ANALYSES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) TREATED WITH SECOND LINE NIVOLUMAB: RESULTS FROM THE MEET-URO 18 STUDY

Rebuzzi S. E. Rescigno P. Signori A.

No description

Uploaded on: February 13, 2024